A comparative study of different treatment modalities of polycystic ovarian syndrome in women of reproductive age group at tertiary care centre
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20232739Keywords:
Letrozole, Lifestyle modification, Metformin, Oral contraceptive pill, Polycystic ovarian syndromeAbstract
Background: Polycystic ovarian syndrome is considered to be a multifaceted disease with a spectrum of manifestation affecting not only women of childbearing age group but also adolescent and post-menopausal women. Most prevalence studies in India prevalence of PCOS as 3.7%-22.5%. Rotterdam consensus conferences, revised diagnostics criteria used. Treatment depends on patient goals ranging from lifestyle modification to drug therapy. It includes: dietary and lifestyle modification, medical management with oral contraceptive pills, metformin, spironolactone, ovulation induction with letrozole, clomiphene.
Methods: Study was conducted in women of reproductive age group with PCOS attending gynaecological OPD at RNT medical college Udaipur. It is a prospective comparative study. Total 290 women included and were followed up for one year.
Results: One year follow up among letrozole group 9 women got conceived, among metformin with letrozole group 23 women got conceived which was statistically significant. Metformin group had significantly greater difference followed by OCP+Metformin group and lifestyle modification group. OCP group and OCP+Metformin group has significant reduction in incidence of hirsutism at one year follow-up. OCP group and OCP+Metformin group had significant reduction in acne at one year follow-up.
Conclusions: Weight reduction is better after metformin along with lifestyle modification than lifestyle modification alone or combine OCP with metformin treatment. Hyperandrogenic symptoms are better responded with OCP then other mode of treatment. Menstrual regularity is well attained by combination treatment of OCP and metformin then monotherapy. Combination of letrozole and metformin is superior as compared to letrozole alone for induction of pregnancy.
References
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219-31.
Panda PK, Rane R, Ravichandran R, Singh S, Panchal H. Genetics of PCOS: A systematic bioinformatics approach to unveil the proteins responsible for the PCOS. Genom Data. 2016;8:52-60.
Franks S, McCarthy MI, Hardy K. Development of polycystic ovarian syndrome: involvement of genetic and environmental factors. Int J Androl. 2006;29(1):278-85.
Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovarian syndrome in young women from North India: A community-based study. Indian. J. Endocrinol. Metab. 2012;16(suppl 2):S389-92.
Bani Mohammad M, Majdi Seghinsara A. Polycystic ovary syndrome (PCOS), Diagnostic criteria, and AMH. Asian Pac J Cancer Prev. 2017;18(1):17-21.
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Revi Dis Pri. 2016;2(1):1-8.
Clark AM. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod. 1995;10(10):2705-12.
Yildiz BO. Approach to the patient: contraception in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100(3):794-802.
Zhao J. The effect of metformin therapy for preventing gestational diabetes mellitus in women with polycystic ovary syndrome: a meta-analysis. Exp Clin Endocrinol Diabetes. 2020;128(3):199-205.
Martin KA. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(4):1233-57.
Legro RS. Ovulation induction in polycystic ovary syndrome: current options. Best Pract Res Clin Obstet Gynaecol. 2016;37:152-9.
Balen AH. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687-708.
Kiddy DS. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;36(1):105-11.
National Institute for Health and Care Excellence: Fertility Problems: Assessment and Treatment. Clinical Guideline CG156. NICE website. Published February 20, 2013. Updated September 6, 2017. Available at: https://www.nice.org.uk/guidance/cg156. Accessed February 22, 2022.
Roque M. Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecol Endocri. 2015;31(12):917-21.
Weiss NS. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome. Cochrane Database Syst Rev. 2015;9:CD010290.
Eijkemans MJ. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod. 2003;18(11):2357-62.
Penzias A, Bendikson K, Butts S, Coutifaris C, Falcone T, Fossum G, et al. Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril. 2017;108(3):426-41.
Morley LC, Tang TM, Balen AH. Metformin therapy for the management of infertility in women with polycystic ovary syndrome: Scientific Impact Paper No. 13. BJOG-AN Inte J Obstet Gynaecol. 2017;124(12):E306-13.
Morley LC. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Coch Data Syst Rev. 2017;11:CD003053.
Yildiz BO. Approach to the patient: contraception in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100(3):794-802.
Legro RS. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-92.
Weiss NS. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome. Coch Data Syst Rev. 2015;9:CD010290.
Penzias A, Bendikson K, Butts S, Coutifaris C, Falcone T, Fossum G, et al. Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril. 2017;108(3):426-41.
Sharpe A. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 1996;2019(12):CD013505.
van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Coch Data Syst Rev. 2015;4:CD010334.
Somani N. Hirsutism: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):247-66.
Brown J. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev. 2009;2:CD000194.
Franik S. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;5:CD010287.
Wolf JE. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol. 2007;46(1):94-8.
van Zuuren EJ. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016;5:CD007628.
Kumar Y, Kotwal N, Singh Y, Upreti V, Somani S, Hari Kumar KV. A randomized, controlled trial comparing the metformin, oral contraceptive pills, and their combination in patients with polycystic povarian syndrome. J Family Med Prim Care. 2018;7:551-6 .
Hoeger KM, Kochmn L, Wixom N, Craig K, Miller RK, Guzick DS. A randomized, 48 week, placebo controlled trial of intense lifestyle modification and/or metformin therapy in overwight women with polycystic ovarian syndrome: a pilot study. Fertil Steril. 2004;82 (2):421-9.
Sonak M, Rathod PD, Patankar US. A prospective observational study of polycystic ovarian syndrome among adolescent and young girls at tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2022;11:2487-93.
Mohsin RA, Saeed AS, Baig MM. Role of letrozole and metformin vs letrozole alone in ovulation induction in patients of polycystic ovarian syndrome. PJMHS. 2019;13 (1):350-2.
Jiang S, Tang T, Sheng Y, Li R, Xu H. The effects of letrozole and metformin combined with targeted nursing care on ovarian function, LH, and FSH in infertile patients with polycystic ovary syndrome. J Health Eng. 2022;2022.
Falsetti L, Gambera A, Tisi G. Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome. Human Reproduction. 2001;16(1):36-42.
Shivangi, Rani SS, Latika. Effect of combined oral contraceptives and cyperoterone acetate-ethinyl estradiol combination on metabolic syndrome in polycystic ovarian syndrome (PCOS). Euro J Mole Clin Med. 2022;9(6):1571-8.
Essah PA, Arrowood JA, Cheang KI, Adawadkar SS, Stovall DW, Nestler JE. Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome. Fertil Steril. 2011;96(2):501-4.
Teede H, Tassone EC, Piltonen T, Malhotra J, Mol BW, Peña A, et al. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta‐analyses. Clin Endocrinol (Oxf). 2019;91(4):479-89.
